HD Biosciences Co., Ltd.

HD Biosciences Shanghai	HD Biosciences San Diego	HD Biosciences New Jersey	WeChat

590 Ruiqing Road,	6122 Nancy Ridge Drive	6 Cedarbrook Drive
Pudong, Shanghai, 201201	San Diego, CA, 92121	Cranbury, NJ 08512
China	US	US

Tel: +86 (21) 5116-3700	Tel: +1 (858) 888-7888	Tel: +1 (609) 606-6680

Email: info@hdbiosciences.com	Email: info-us@hdbiosciences.com	Email: info-us@hdbiosciences.com

SEE OUR GLOBAL SITES >

沪公网安备 31011502003320号

Metabolic diseases

Oncology

Neurosciences

Inflammation & Immunology

Liver diseases

Infectious diseases

Target validation &
target engagement

In vitro assays for
Hit ID

Functional &
phenotypic assays

Glucose uptake

Fatty acid oxidation

Insulin secretion
in islets (GSIS)

Lipogenesis & lipolysis

Insulin signaling
pathway

Multiplexing profiling with MSD panels (metabolic markers)

Disease models

Obesity

Dyslipidemia

Hyperinsulinemic euglycemic clamp

Target validation

Tumor cell panel & screening

Cell proliferation & cell cycle

Cell invasion & migration

3-D cell based assay

Cell signalingpathway & MOA

Cancer metabolism

In vivo tumor models

Xenograft models

Orthotopic models

Stem cell tumor models

Metastasis models

Predictive biomarkers and companion diagnostics

TCPD(Tumor Cell Panel Database)

In vitro Neurosciences

Neuronal targets assay development & screening

Neurotoxicity/cell death

Neuromorphology & histology

MOA & neuronal functional pathway analysis

Anxiety including PTSD model

Cell based phenotypic assay

Cytokine & chemokine measurement

T cell & B cellproliferation assay

Chemotaxis assay

Animal models

Experimental allergic encephalomyelitis (EAE)

Asthma model

Lung inflammation/fibrosis

Rheumatoid arthritis

Skin inflammation

Inflammatory BowelDisease (IBD)

Passive CutaneousAnaphylaxis (PCA)

MSU InducedInflammatory Gout

Carrageenan inducedair pouch model

Post-antibiotic-effect (PAE) study

Checkerboard assay

Macromolecule synthesis pathway study

Resistant test

Nephrotoxicity assay

沪公网安备 31011502003320号

•

The Latest Generation of Auto Patch Clamp Platform Launched at HDB

We are excited to announce the installation and operation of SyncroPatch 384, the latest generation of automated patch clamp (APC) system which can be implemented into all phases of drug discovery.

•

WuXi Biology/HD Biosciences Presented at webinar of "New Technologies for Target Discovery and Validation"

Novel target discovery and validation are the most crucial steps and prerequisites for successful drug development.

•

HD Biosciences Merges with WuXi AppTec

HD Biosciences Co., Ltd. (HDB), a leading biology-focused preclinical drug discovery contract research organization (CRO), today announces its merge with WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform.

More...